These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Differential behavior of the sub-sites of cytochrome 450 active site in binding of substrates, and products (implications for coupling/uncoupling). Narasimhulu S Biochim Biophys Acta; 2007 Mar; 1770(3):360-75. PubMed ID: 17134838 [TBL] [Abstract][Full Text] [Related]
25. Modes of heme binding and substrate access for cytochrome P450 CYP74A revealed by crystal structures of allene oxide synthase. Li L; Chang Z; Pan Z; Fu ZQ; Wang X Proc Natl Acad Sci U S A; 2008 Sep; 105(37):13883-8. PubMed ID: 18787124 [TBL] [Abstract][Full Text] [Related]
27. Molecular modeling of mammalian cytochrome P450s. Friedman FK; Robinson RC; Dai R Front Biosci; 2004 Sep; 9():2796-806. PubMed ID: 15353315 [TBL] [Abstract][Full Text] [Related]
28. Structure, electronic properties and catalytic behaviour of an activity-enhancing CYP102A1 (P450(BM3)) variant. Whitehouse CJ; Yang W; Yorke JA; Tufton HG; Ogilvie LC; Bell SG; Zhou W; Bartlam M; Rao Z; Wong LL Dalton Trans; 2011 Oct; 40(40):10383-96. PubMed ID: 21603690 [TBL] [Abstract][Full Text] [Related]
29. Structure of cytochrome P450eryF: substrate, inhibitors, and model compounds bound in the active site. Cupp-Vickery JR; Poulos TL Steroids; 1997 Jan; 62(1):112-6. PubMed ID: 9029724 [TBL] [Abstract][Full Text] [Related]
30. Common active site architecture and binding strategy of four phenylpropanoid P450s from Arabidopsis thaliana as revealed by molecular modeling. Rupasinghe S; Baudry J; Schuler MA Protein Eng; 2003 Oct; 16(10):721-31. PubMed ID: 14600201 [TBL] [Abstract][Full Text] [Related]
31. Crystal structures of epothilone D-bound, epothilone B-bound, and substrate-free forms of cytochrome P450epoK. Nagano S; Li H; Shimizu H; Nishida C; Ogura H; Ortiz de Montellano PR; Poulos TL J Biol Chem; 2003 Nov; 278(45):44886-93. PubMed ID: 12933799 [TBL] [Abstract][Full Text] [Related]
32. Comparison of intrinsic dynamics of cytochrome p450 proteins using normal mode analysis. Dorner ME; McMunn RD; Bartholow TG; Calhoon BE; Conlon MR; Dulli JM; Fehling SC; Fisher CR; Hodgson SW; Keenan SW; Kruger AN; Mabin JW; Mazula DL; Monte CA; Olthafer A; Sexton AE; Soderholm BR; Strom AM; Hati S Protein Sci; 2015 Sep; 24(9):1495-507. PubMed ID: 26130403 [TBL] [Abstract][Full Text] [Related]
33. Crystal structures of substrate-free and retinoic acid-bound cyanobacterial cytochrome P450 CYP120A1. Kühnel K; Ke N; Cryle MJ; Sligar SG; Schuler MA; Schlichting I Biochemistry; 2008 Jun; 47(25):6552-9. PubMed ID: 18512957 [TBL] [Abstract][Full Text] [Related]
34. Riboflavin Is Directly Involved in N-Dealkylation Catalyzed by Bacterial Cytochrome P450 Monooxygenases. Zhang C; Lu M; Lin L; Huang Z; Zhang R; Wu X; Chen Y Chembiochem; 2020 Aug; 21(16):2297-2305. PubMed ID: 32243060 [TBL] [Abstract][Full Text] [Related]
35. A three-dimensional protein model for human cytochrome P450 2D6 based on the crystal structures of P450 101, P450 102, and P450 108. de Groot MJ; Vermeulen NP; Kramer JD; van Acker FA; Donné-Op den Kelder GM Chem Res Toxicol; 1996; 9(7):1079-91. PubMed ID: 8902262 [TBL] [Abstract][Full Text] [Related]
36. Applications of microbial cytochrome P450 enzymes in biotechnology and synthetic biology. Girvan HM; Munro AW Curr Opin Chem Biol; 2016 Apr; 31():136-45. PubMed ID: 27015292 [TBL] [Abstract][Full Text] [Related]
37. Role of active site water molecules and substrate hydroxyl groups in oxygen activation by cytochrome P450 158A2: a new mechanism of proton transfer. Zhao B; Guengerich FP; Voehler M; Waterman MR J Biol Chem; 2005 Dec; 280(51):42188-97. PubMed ID: 16239228 [TBL] [Abstract][Full Text] [Related]
38. Substrate selectivity of drug-metabolizing cytochrome P450s predicted from crystal structures and in silico modeling. Dong D; Wu B Drug Metab Rev; 2012 Feb; 44(1):1-17. PubMed ID: 22242930 [TBL] [Abstract][Full Text] [Related]
39. Structure and function of cytochromes P450 2B: from mechanism-based inactivators to X-ray crystal structures and back. Halpert JR Drug Metab Dispos; 2011 Jul; 39(7):1113-21. PubMed ID: 21502194 [TBL] [Abstract][Full Text] [Related]